ID
27402
Beschreibung
Study ID: 103094 Clinical Study ID: ARI103094 Study Title: ARI103094-Follow-Up Study for REDUCE Study Subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00883909 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Neoplasms, Prostate CRF Seiten: 934-977
Stichworte
Versionen (2)
- 13.11.17 13.11.17 -
- 26.11.17 26.11.17 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
13. November 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Contact #1 Year 1 GSK study Prostatic neoplasms NCT00883909
Contact #1 Year 1 GSK study Prostatic neoplasms NCT00883909
- StudyEvent: ODM
Beschreibung
Subject contact
Beschreibung
If YES, record the date and type of contact.
Datentyp
text
Beschreibung
Date of contact
Datentyp
date
Beschreibung
Type of contact
Datentyp
text
Beschreibung
If YES, ensure that all questions in the CONTACT #1 section have been completed. If NO, check primary reason interview was not completed and do not complete the questions in the section below ‘ CONTACT #1’.
Datentyp
text
Beschreibung
If subject died, record details on the SERIOUS ADVERSE EVENT pages.
Datentyp
text
Beschreibung
Other primary reason interview was not completed
Datentyp
text
Beschreibung
CONTACT #1 - Since your participation in the REDUCE study (REDUCE 4 Year Contact):
Beschreibung
If YES, Record the date of collection and local PSA results on the PSA RESULTS page.
Datentyp
text
Beschreibung
If YES, • Enter the biopsy information and the local pathology results on the LOCAL PATHOLOGY RESULTS page. • Send biopsy sample to Central Pathology for Confirmatory Review only if the result is positive for prostate cancer. • If biopsy is positive for PCa enter any available new TNM stage information on the TNM STAGING HISTORY page.
Datentyp
text
Beschreibung
If YES, • Enter surgical treatment for PCa on the PROSTATIC SURGICAL INTERVENTION page; and, • For radical prostatectomy, enter any local pathology information/ result on LOCAL PATHOLOGY RESULTS page. • For radical prostatectomies, send surgical sample to Central Pathology for confirmatory review, regardless of whether the result is positive or negative for prostate cancer. • For all prostate surgeries other than radical prostatectomies, send surgical sample to Central Pathology for confirmatory review only if the result is positive for prostate cancer. • Enter non-surgical treatment for PCa, on the NON-SURGICAL INTERVENTION FOR PROSTATE CANCER page. • Complete any further TNM staging information on the TNM STAGING HISTORY page.
Datentyp
text
Beschreibung
If YES, • Enter the prostate surgery information on the PROSTATE SURGICAL INTERVENTION page; and, • Enter local pathology results for the surgery on the LOCAL PATHOLOGY RESULTS page. • Send surgical sample to Central Pathology for confirmatory review only if the result is positive for prostate cancer. • Complete any further TNM staging information on the TNM Staging History page.
Datentyp
text
Beschreibung
medical problems or hospitalisations
Datentyp
text
Beschreibung
If YES, Complete the SERIOUS ADVERSE EVENT pages and ensure they are faxed to GSK within 24 hours of becoming aware of the event.
Datentyp
text
Beschreibung
Chronic concomitant medications include all prescription and nonprescription medication including vitamins, supplements and herbal remedies. Specifically include the use of dutasteride [Avodart ®] or finasteride [Proscar ® and Propecia ®]. If YES, • Enter information for all changes in chronic medications on the CONCOMITANT MEDICATIONS page(s).
Datentyp
text
Ähnliche Modelle
Contact #1 Year 1 GSK study Prostatic neoplasms NCT00883909
- StudyEvent: ODM